Primary diagnosis of metastatic breast cancer in the third trimester of pregnancy: A case report and review of the literature
Authors:
- 16 February 2012
- journal article
- case report
- Published by Wiley in Journal of Obstetrics and Gynaecology Research
- Vol. 38 (3) , 589-592
Abstract
To the best of our knowledge, we are presenting the first documented primary diagnosis of a 32-year-old pregnant patient at 29 + 4 weeks' gestation with poorly differentiated, metastatic scirrhous breast cancer, with negative hormone receptors, HER-2/neu receptor overexpression and metastases in the lumbar spine. The patient was administered neoadjuvant chemotherapy with vinorelbine and trastuzumab, and received ibandronate for the bone metastases. The tumor responded well to treatment; however, treatment was associated with anhydramnios, probably related to the trastuzumab treatment. Delivery was planned for 33 + 5 weeks' gestation by cesarean section due to concurrent breech presentation and anhydramnios, and the infant is in good health. After delivery, the patient underwent a mastectomy. Following completion of six courses of vinorelbine and ongoing treatment with trastuzumab and ibandronate, the patient's tumor went into regression and currently the patient does not present with any clinical evidence of disease.Keywords
This publication has 15 references indexed in Scilit:
- Intravenous bisphosphonate treatment and pregnancy: its effects on mother and infant bone healthOsteoporosis International, 2010
- Herceptin (trastuzumab) therapy in a twin pregnancy with associated oligohydramniosAmerican Journal of Obstetrics and Gynecology, 2009
- Cytotoxic chemotherapy for pregnancy-associated breast cancer: single institution case seriesJournal of Oncology Pharmacy Practice, 2009
- Pregnancy outcome following in utero exposure to bisphosphonatesBone, 2009
- Emerging therapeutic options for breast cancer chemotherapy during pregnancyAnnals of Oncology, 2007
- Trastuzumab Use for Metastatic Breast Cancer in PregnancyObstetrics & Gynecology, 2007
- Treatment of Metastatic Breast Cancer with Trastuzumab and Vinorelbine During PregnancyClinical Breast Cancer, 2005
- Herceptin (Trastuzumab) Therapy During Pregnancy: Association With Reversible AnhydramniosObstetrics & Gynecology, 2005
- Breast carcinoma in pregnant womenCancer, 2003
- Vinorelbine in pregnancyEuropean Journal of Cancer, 1997